We are proud to announce that Maculaser is now part of PhotonMed, a €32 million European Union (Chips Joint Undertaking, Chips JU)-funded initiative spanning 9 countries. This ambitious collaboration brings together leading research institutes and industrial partners to advance health care with cutting-edge photonics-based solutions.
As part of this initiative, Maculaser is integrating innovative photonic technologies into our treatment platform to enhance outcomes for patients with macular degeneration and other retinal conditions. Together, we aim to redefine the future of retinal care and improve the lives of millions.
Learn more: https://photonmed.eu
#PhotonMed #Maculaser #RetinalCare #MacularDegeneration #MedicalDevices #Photonics
